Precision antiplatelet therapy for the prevention of ischaemic stroke

作     者：David Wang 

作者机构：Neurovascular DivisionDepartment of NeurologyBarrow Neurological InstituteSt.Joseph's Hospital and Medical CenterPhoenixArizonaUSA 

出 版 物：《Stroke & Vascular Neurology》 (卒中与血管神经病学（英文）)

年 卷 期：2022年第7卷第2期

页      面：89-91页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 100204[医学-神经病学] 10[医学] 

主　　题：prevention death Aspirin 

摘      要：Stroke happens to people of all ages and has become the leading cause of disability in the world.1 It is also the leading cause of death in China and fifth-leading cause of death in the USA.23 Prevention of stroke is the best *** use of antiplatelet therapy is one of the main prevention *** is the only antiplatelet drug indicated for primary or secondary stroke *** the invention of aspirin nearly 120 years ago,more antiplatelet agents are *** can select one antiplatelet drug or the combination for a specific patient with a specific subtype of ischaemic *** kind of precision antiplatelet therapy can maximise the benefit and lower the risk of haemorrhagic complications.